Network imaging biomarkers: insights and clinical applications in Parkinson's disease
- 1 July 2018
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 17 (7) , 629-640
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Molecular nexopathies: a new paradigm of neurodegenerative diseaseTrends in Neurosciences, 2013
- Metabolic network as a progression biomarker of premanifest Huntington’s diseaseJournal of Clinical Investigation, 2013
- The natural history of multiple system atrophy: a prospective European cohort studyThe Lancet Neurology, 2013
- Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [18F]Fluorodeoxyglucose Positron Emission Computed Tomography StudyDementia and Geriatric Cognitive Disorders, 2013
- Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromesNeuroImage: Clinical, 2013
- Functional brain imaging of cognitive dysfunction in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Network correlates of disease severity in multiple system atrophyNeurology, 2012
- Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's diseaseBrain, 2011
- Metabolic correlates of subthalamic nucleus activity in Parkinson's diseaseBrain, 2008
- THE BASAL GANGLIA: FOCUSED SELECTION AND INHIBITION OF COMPETING MOTOR PROGRAMSProgress in Neurobiology, 1996